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Like other apicomplexan parasites, Toxoplasma gondii
actively invades host cells using a combination of
secretory proteins and an acto-myosin motor system.
Micronemes are the first set of proteins secreted
during invasion that play an essential role in host
cell entry. Many microneme proteins (MICs) function
in protein complexes, and each complex contains at
least one protein that displays a cleavable propeptide.
Although MIC propeptides have been implicated in
forward targeting to micronemes, the specific amino
acids involved have not been identified. It was also
not known if the propeptide has a general function in
MICs trafficking in T. gondii and other apicomplexans.
Here we show that propeptide domains are extensively
interchangeable between T. gondii MICs and also with
that of Eimeria tenella MIC5 (EtMIC5), suggesting a
common mechanism of function. We also performed N-
terminal deletion and mutational analysis of M2AP and
MIC5 propeptides to show that a valine at position +3
(relative to signal peptidase cleavage) of proM2AP and a
leucine at position +1 of proMIC5 are crucial for targeting
to micronemes. Valine and leucine are closely related
amino acids with similar side chains, implying a similar
mode of function, a notion that was confirmed by correct
trafficking of TgM2AP-V/L and TgMIC5-L/V substitution
mutants. Propeptides of AMA1, MIC3 and EtMIC5 have
valine or leucine at or near the N-termini and mutagenesis
of these conserved residues validated their role in
microneme trafficking. Collectively, our findings suggest
that discrete, aliphatic residues at the extreme N-termini
of proMICs facilitate trafficking to the micronemes.
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Secretory proteins are released from eukaryotic cells
either in a constitutive or regulated manner. Proteins
destined for constitutive secretion generally do not carry
codes for trafficking to specific destinations and are
secreted soon after synthesis. In contrast, regulated
secretion often involves precise trafficking based on
specific forward targeting elements contained within the
proteins, storage in specific compartments and secretion
in response to internal or external stimuli. Although
regulated secretion has been the subject of intense
research in recent years, the sorting signals that play
a role in protein targeting to their destination organelle
remain poorly defined in many biological systems (1).
Toxoplasma gondii is an obligatory intracellular parasite
that causes toxoplasmosis in humans and is classified
in the phylum Apicomplexa. The phylum also includes
pathogens of medical and veterinary importance such as
Plasmodium, the causative agent of malaria, and Eimeria,
which causes coccidiosis in poultry. Toxoplasma gondii
infection is often asymptomatic in healthy individuals,
but it can cause fatal toxoplasmic encephalitis in
immunocompromised patients such as those infected
with HIV or patients undergoing immunosuppressive
therapy during organ transplantation procedures (2).
Toxoplasma gondii entry into host cells is an essential step
in its obligatory intracellular lifestyle and is thus considered
potentially vulnerable to intervention. Toxoplasma gondii
host cell invasion is an active process that involves its
own cytoskeleton machinery and regulated secretion
of proteins from distinct secretory organelles including
micronemes and rhoptries (3,4). Micronemes are cigar-
shaped organelles located at the apical end of the parasite.
The contents of micronemes are discharged in response
to a rise in intracellular calcium during gliding motility and
initial contact of the parasite’s apical end with the host cell
surface (5–8). Microneme proteins are not only crucial for
binding to the host cell prior to entry but are also essential
for parasite gliding motility, the basis for active invasion (9).
Microneme proteins generally function in complexes
consisting of one transmembrane protein and one or
more non-anchored proteins in which at least one
protein contains a cleavable propeptide (10,11). MIC2-
M2AP (9) and MIC3-MIC8 (12) are two of the key
microneme complexes necessary for invasion. MIC2
is a thrombospondin-related anonymous protein family
transmembrane protein that interacts with both host
cell receptors and the cytoskeletal machinery of the
parasite (13). M2AP is a soluble protein and contains
a 24-amino acid N-terminal propeptide that is cleaved
within the parasite endosomal system, which was recently
shown to act as a conduit to the micronemes (14).
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MIC2 forms a heterohexameric complex with M2AP in
the endoplasmic reticulum (ER) and remains associated
during essential steps of attachment and invasion. Several
studies have clearly established that the MIC2-M2AP
complex is a central and rate-limiting component of the
motility and invasion machinery of T. gondii (9,13,15,16).
Accordingly, parasites in which these genes are knocked
out or mutated are significantly compromised with regard
to invasion and virulence in the mouse model (9,16). MIC8
is a transmembrane microneme protein that forms a
complex with MIC3. Targeted disruption of MIC8 impairs
moving junction formation thus significantly compromising
parasite invasion (12).
Efficient functioning of microneme protein complexes
requires correct trafficking of these proteins from their
initial site of synthesis in the ER to the staging
site for secretion, the micronemes. Although previous
studies have shown that the cytoplasmic domains of
MIC2 and MIC6 contain a microneme targeting motif
(EIEYE) (17,18), recent studies have shown that these
elements are not sufficient for directing the complex
to the micronemes (15). In M2AP knockout (M2APKO)
parasites, MIC2 is retained in the Golgi thus implying
that soluble M2AP protein plays a role in trafficking (15).
Further studies on M2AP showed that deletion of M2AP-
propeptide (M2APpro) results in impaired trafficking of
the MIC2-M2AP complex, indicating that the propeptide is
necessary for trafficking to micronemes (19). Interestingly,
M2APpro parasites also display a delayed time-to-
death phenotype that is similar to M2APKO parasites
thus emphasizing the relation between propeptide-based
trafficking of this complex and T. gondii virulence (19). A
general role for microneme propeptides is also supported
by studies on MIC5 and MIC3 as the deletion of their
propeptides results in retention or mistargeting within the
trafficking pathway (20,21). Additionally, a recent study
looking at transmembrane microneme proteins such
as MIC8, MIC8.2, MIC16 and AMA1 established that
cytoplasmic domains do not contain microneme targeting
information, suggesting that either the ectodomain or
soluble proteins within the complex contains microneme
targeting information (22).
Although it is now established that microneme propep-
tides are involved in trafficking, their precise role in facil-
itating entry into the micronemal pathway remains to be
elucidated. For example, it is not known whether the for-
ward targeting function of microneme propeptide domains
is limited to T. gondii or shared by other apicomplexans.
It is also unclear if the propeptide domains are compe-
tent only on their cognate proteins or whether they are
widely interchangeable. Finally, as no conserved motifs
have been identified in proMICs it remains unclear if tar-
geting information is sequence specific. Hence this study
was undertaken to address these questions. We show
that propeptide domains appear to be extensively inter-
changeable among different microneme proteins within
T. gondii and also with the related apicomplexan parasite
Eimeria tenella, suggesting a common mechanism of func-
tion. We also show by deletion and mutational analysis
of microneme propeptides that aliphatic residues near the
N-terminus act as important determinants of microneme
trafficking.
Results
Microneme propeptide domains are extensively
interchangeable
Previous work had demonstrated that microneme protein
propeptides are required for trafficking and in at least one
case they are functionally interchangeable (20). We sought
to expand this analysis to other microneme propeptides
in T. gondii and also in the related apicomplexan
parasite E. tenella (Figure 1A). Having parasites deficient
in either M2AP or MIC5 provided an ideal opportunity
to study microneme trafficking in a background free of
interference from expression of endogenous protein.
To determine if microneme propeptides are widely
interchangeable among different microneme proteins
within T. gondii and also with E. tenella, propeptide
swapping experiments were performed. We designed
plasmid constructs in which the M2AP propeptide
is replaced with propeptides from AMA1, MIC3 or
E. tenella MIC5 (EtMIC5) and cotransfected them along
with a selectable marker (pTUB/DHFR) into M2APKO
parasites. The transfected parasites were cultured in
the presence of pyrimethamine to obtain parasite cell
lines stably expressing AMA1proM2AP, MIC3proM2AP
or EtMIC5proM2AP. The location of mature M2AP in
intracellular parasites was analyzed by immunostaining
with a polyclonal antibody against M2AP. Detection
of MIC10 was used as a control for apical staining.
Results showed that most of the mature M2AP protein
colocalized with MIC10 indicating that AMA1, MIC3 or
EtMIC5 propeptides can correctly deliver M2AP to the
micronemes (Figure 1B,C). These results suggest that the
forward targeting function of microneme propeptides is
conserved not only among different microneme proteins
within T. gondii but also within the coccidia. The
finding that microneme propeptide domains are able to
substitute for one another in turn suggests that they
likely function via a similar mechanism. To determine
if propeptide-dependent trafficking is sequence specific,
we generated parasites stably expressing a sequence-
scrambled propeptide of M2AP (M2AP-SCR) fused to
mature M2AP and examined by immunofluorescence
assay (IFA). In this case, localization of M2AP with the
scrambled propeptide was clearly distinct from MIC10,
thus indicating that the order of amino acids in the
propeptide is important for trafficking. The residual ∼20%
colocalization of M2AP-SCR with MIC10 is due to a
combination of small amounts of M2AP-SCR that reach
the micronemes and the presence of some MIC10
in the intermediate compartment where M2AP-SCR is
retained. To examine the nature of propeptide processing,
we performed immunoblot analysis of parasite lysates





Figure 1: Legend on next page.
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Figure 2: The MIC5 propeptide is interchangeable with that of M2AP. A) Location of mature MIC5 in intracellular parasites
expressing WT MIC5 (upper panels) or M2APproMIC5 (lower panels) was examined by IFA using anti-MIC5 and anti-MIC10 antibodies.
Scale bar: 2 μm. B) Quantification of MIC5 and MIC10 colocalization. Bars represent standard error of the mean (SEM); ns, not
statistically different from WT, i.e. p > 0.05, one-sample t-test. C) Parasites stably expressing WT-MIC5 and M2AP-MIC5 were analyzed
by immunoblotting with anti-MIC5 and anti-proM2AP antibodies.
using anti-proM2AP and anti-M2AP antibodies. The results
showed that all chimeric M2AP proproteins were of
expected size and were processed correctly except
M2AP-SCR (Figure 1D). The lack of M2AP-SCR processing
is likely due to disruption of the residues involved in
protease recognition, as these residues lie mainly within
the propeptide (19).
We also made a plasmid construct in which the M2AP
propeptide is linked to mature MIC5 and cotransfected
with pTUB/DHFR into MIC5KO parasites. The hybrid
protein, M2APproMIC5, showed apical localization similar
to MIC10, indicating that the M2AP propeptide can target
mature MIC5 to micronemes (Figure 2A,B). Immunoblot
analysis using anti-proM2AP and anti-MIC5 antibodies
confirmed the chimeric nature of M2APproMIC5 protein
and also its correct processing (Figure 2C). These results
further confirm that propeptide domains are indeed
extensively interchangeable in T. gondii.
The third residue of the M2AP propeptide (valine) is
important for microneme trafficking
In an initial attempt to identify conserved residues in
propeptides necessary for microneme targeting we per-
formed comparative sequence analysis of microneme
propeptides in T. gondii (see also Figure 8A). Although
all the microneme propeptide sequences have a net basic
or neutral charge that contrasts with the acidic nature of
the mature protein, no conserved motifs were observed.
Hence, we moved forward with N-terminal deletion analy-
sis of the M2AP propeptide to empirically identify residues
necessary for trafficking. We designed plasmid constructs
that contain serial deletions of the 24 amino acid M2AP
propeptide. Initially seven constructs were made with
deletions of 2 (2), 6 (6), 10 (10), 14 (14), 18 (18),
22 (22) and 24 (24, M2APpro) amino acids of the
M2AP propeptide (Figure 3A). The plasmid constructs
were transfected into M2APKO parasites and parasite cell
lines stably expressing M2AP propeptide deletion mutants
were obtained and examined by IFA. The results showed
that while M2AP is correctly targeted to micronemes in
parasites expressing full-length M2AP (M2AP-WT) and
M2AP2, it is largely retained in central apical location in
all the subsequent deletion mutants (Figures 3B,C and S1).
Additional staining experiments showed that the M2AP
trafficking mutants reside within the endosomal system
where they displayed an overlapping distribution with the
late endosomal markers, Rab7 and VP1 (Figure 3D). This
mislocalization is similar to M2APpro mutants described
previously (19,23). Immunoblot analysis with anti-M2AP
antibody revealed that despite the mis-trafficking of
M2AP6 and subsequent deletion constructs, propeptide
processing of the mutants still occurs to a certain extent
(Figure 3E). This is consistent with previous observations
that M2AP processing occurs within the endosomal sys-
tem and that M2AP trafficking and processing are mostly
independent events (19,21). This first series of deletion
Figure 1: The M2AP propeptide is interchangeable with other propeptides from T. gondii and E. tenella. A) Schematic
representation of microneme complexes: MIC2-M2AP, AMA1, MIC3-MIC8, MIC5 of T. gondii and EtMIC4-MIC5 of E. tenella. B)
Location of mature M2AP in intracellular parasites was examined by IFA using anti-M2AP and anti-MIC10 antibodies. MIC10 was used
as the control for microneme staining. Arrows denote the site where the mature M2AP is retained in the secretory pathway. Displayed
to the left of each image series is a schematic representation of constructs containing wild-type mature M2AP and replacement
propeptides from AMA1, MIC3, EtMIC5 or sequence-scrambled M2AP propeptide (SCR). Scale bar: 2 μm. C) For this experiment
and all subsequent experiments, the extent of colocalization of M2AP (or MIC5) and MIC10 was quantified by determining Pearson’s
coefficient value using AXIOVISION software. Colocalization values obtained for parasites transfected with M2AP-WT (or MIC5-WT) were
set at 100%. Results are from two experiments each measuring the colocalization within at least four vacuoles each with four parasites.
Bars represent standard error of the mean (SEM); ns, not statistically different from WT, i.e. p > 0.05, one-sample t-test. *p < 0.05. D)
Parasites stably transfected with construct for expression of WT M2AP or replacement propeptide were analyzed by immunoblotting
with anti-M2AP and anti-proM2AP antibodies.







Figure 3: Initial N-terminal serial deletion analyses of M2AP propeptide suggests that the ‘VGNP’ region contains important
residues required for trafficking. A) Schematic representation and sequences of full-length and N-terminal serial deletion constructs of
M2AP propeptide. An arrow denotes the proteolytic cleavage site. B) Location of mature M2AP in intracellular parasites was examined
by IFA using anti-M2AP and anti-MIC10 antibodies. Arrows denote the site where the mature M2AP is retained in the secretory pathway
in parasites that showed defective trafficking. Scale bar: 2 μm. C) Quantification of M2AP and MIC10 colocalization. Bars represent
standard error of the mean (SEM); ns, not statistically different from WT, i.e. p > 0.05, one-sample t-test. *p < 0.05. D) Upper panel
shows double immunolocalization of M2AP6 parasites with anti-M2AP and anti-VP1 antibodies. Lower panel shows M2AP6 parasites
transiently transfected with HA-tagged Rab7 and stained with anti-M2AP and anti-HA antibodies. E) Parasites stably transfected with
full-length propeptide (WT) and deletion mutants were analyzed by immunoblotting with anti-M2AP.
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Figure 4: Fine mapping of the ‘VGNP’ region of M2AP propeptide shows that the third residue, valine, is important for
trafficking. A) Schematic representation and sequences of full-length, deletion and replacement mutants of M2AP propeptide. An arrow
denotes the proteolytic cleavage site. B) Location of mature M2AP in intracellular parasites was examined by IFA using anti-M2AP and
anti-MIC10 antibodies. Arrows denote the site where the mature M2AP is retained in the secretory pathway in mutants that showed
defective trafficking. Scale bar: 2 μm. C) Quantification of M2AP and MIC10 colocalization. Bars represent standard error of the mean
(SEM); *p < .05, one sample t test. D) Parasites stably transfected with full-length propeptide, deletion or replacement mutants were
analyzed by immunoblotting with anti-M2AP.
analysis results indicated that a forward targeting element
is located between the second and seventh residues of
the M2AP propeptide, i.e. within the sequence ‘VGNP’.
For finer dissection, we made deletion constructs that
contained deletions of 3 (3) and 4 (4) amino acids of
the M2AP propeptide (Figure 4A) and transfected into
M2APKO parasites. Both deletion constructs showed
aberrant trafficking, thus indicating that the third residue
of the M2AP propeptide (valine) is important for correct
targeting (Figure 4B,C). To validate this finding, we made
parasite cell lines in which the third residue valine
was replaced with either alanine or lysine. Analysis by
IFA showed that M2AP was mis-trafficked in both the
replacement mutants and the trafficking defect was
more severe when valine was replaced with lysine
(Figure 4B,C), thus confirming that valine is indeed
important for microneme targeting. Immunoblot analysis
indicated that propeptide processing was still observed to
a large extent in trafficking-defective parasites (Figure 4D),
consistent with the earlier findings.
The first residue of the MIC5 propeptide (leucine)
plays a critical role in microneme trafficking
M2AP propeptide analysis indicated that residues near
the N-terminus are important for trafficking. To test if this
is also true for MIC5, we performed N-terminal deletion
analyses of the 14 amino acid MIC5 propeptide. In the first
step, we generated seven plasmid constructs containing
serial deletions of 2 (2), 4 (4), 6 (6), 8 (8), 10 (10),
12 (12) and 14 (14, MIC5pro) amino acids of the
MIC5 propeptide (Figure 5A) and transfected into MIC5KO
parasites. Parasite populations stably expressing WT and
deletion constructs were analyzed by IFA using antibodies
against MIC5 and MIC10. Deletion of the first two amino
acids of the MIC5 propeptide was sufficient to impair
trafficking to the micronemes (Figure 5B,C), indicating







Figure 5: N-terminal serial deletion analysis of MIC5 propeptide suggests that a leucine near the N-terminus is important for
trafficking. A) Schematic representation and sequences of full-length and N-terminal serial deletion constructs of MIC5 propeptide. An
arrow denotes the proteolytic cleavage site. B) Location of mature MIC5 in intracellular parasites was examined by IFA using anti-MIC5
and anti-MIC10 antibodies. Arrows denote the site where the mature MIC5 is retained in the secretory pathway in parasites that showed
defective trafficking. Scale bar: 2 μm. C) Quantification of MIC5 and MIC10 colocalization. Bars represent standard error of the mean
(SEM); ns, not statistically different from WT, i.e. p > 0.05, one-sample t-test. *p < 0.05. D) Double immunolocalization of MIC52
parasites with anti-MIC5 and anti-VP1 or GRA4. Approximate positions of parasites are indicated by dash-lined ovals. E) Parasites stably
transfected with full-length propeptide or deletion mutants were analyzed by immunoblotting with anti-MIC5.
that similar to M2AP, the key residues are displayed
near the N-terminus of the propeptide. Interestingly,
the localization of MIC5 in trafficking-defective parasites
showed a strikingly different pattern from that seen
previously with M2AP trafficking mutants. A small fraction
of MIC5 colocalized with the late endosome marker
VP1 (Figure 5D, upper panels), but most of the protein
showed distinct localization that did not correspond to
dense granules (Figure 5D, lower panels) or ER (data not
shown).
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Interestingly, deletion of an additional two amino acids
(MIC54) resulted in restoration of correct microneme
localization. Subsequent deletion mutants showed defec-
tive trafficking similar to the 14 (MIC5pro) mutant
(Figure 5B,C). Immunoblot analysis with anti-MIC5 anti-
bodies showed that most of the MIC5 does not undergo
proteolytic processing in trafficking-defective parasites
(2, 6 and 10) (Figure 5E). As processing of MIC5
likely occurs in the endosomal system (24), the lack of
processing is consistent with arrest or diversion of mutant
proteins prior to reaching the processing site in the endo-
somes.
We noticed that both the wild-type MIC5 propeptide
(MIC5-WT) and the MIC54 mutant that showed restored
trafficking have a leucine is displayed at the N-terminus.
To test the requirement for an N-terminal leucine, we
created parasites expressing mutant MIC5 in which this
residue was deleted (MIC51) or replaced with lysine
(MIC5-L1K). MIC5 failed to colocalize with MIC10 in
both of these parasite lines (Figure 6B,C). To further
confirm the importance of an N-terminal leucine, we made
parasites expressing mutant MIC5 in which the first two
residues of the propeptide were deleted and the third
residue serine was replaced with leucine (MIC52-SL).
These parasites showed extensive MIC5 colocalization
with MIC10 (Figure 6B,C) thus confirming that a terminal
leucine is indeed necessary for correct targeting of
MIC5. This was further confirmed by immunoblot
analysis using anti-MIC5 antibodies (Figure 6D). Very little
processed MIC5 was observed in MIC51 and MIC5-
L1K parasites, whereas efficient processing of MIC52-
SL occurred. These findings are also consistent with
trafficking-defective mutants of MIC5 being arrested or
diverted prior to reaching the processing site in the late
endosomes.
Valine and leucine are interchangeable in M2AP and
MIC5 propeptides
Leucine and valine are closely related amino acids with
side chains differing by only one methylene group. To
test if valine and leucine can substitute for each other
in M2AP and MIC5 propeptides, we made parasite cell
lines in which valine of M2AP is replaced with leucine
(M2AP-V3L) or leucine of MIC5 propeptide is replaced with
valine (MIC5-L1V) (Figure 7A). Results showed that M2AP-
V3L and MIC5-L1V extensively colocalize with MIC10
(Figure 7A,B) thus indicating that valine and leucine are





Figure 6: Fine mapping of MIC5 propeptide confirmed that an N-terminal leucine is important for trafficking. A) Schematic
representation and sequences of full-length, deletion and replacement mutants of MIC5 propeptide. An arrow denotes the proteolytic
cleavage site. B) Location of mature MIC5 in intracellular parasites was examined by IFA using anti-MIC5 and anti-MIC10 antibodies.
Arrows denote the sites where the mature MIC5 is retained in intracellular parasites that showed defective trafficking. Scale bar: 2 μm.
C) Quantification of MIC5 and MIC10 colocalization. Bars represent standard error of the mean (SEM); ns, not statistically different from
WT, i.e. p > 0.05, one-sample t-test. *p < 0.05. D) Parasites stably transfected with full-length propeptide or deletion mutants were
analyzed by immunoblotting with anti-MIC5.




Figure 7: Valine and leucine are largely interchangeable in M2AP and MIC5 propeptides. A) Schematic representation of plasmid
constructs in which valine of M2AP propeptide is replaced with leucine and leucine of MIC5 propeptide is replaced with valine. The
propeptide sequences along with mutated residues are also shown. B) Location of mature MIC5 and M2AP in intracellular parasites
was examined by IFA using anti-M2AP or anti-MIC5 and anti-MIC10 antibodies. Scale bar: 2 μm. C) Quantification of M2AP or MIC5 and
MIC10 colocalization. Bars represent standard error of the mean (SEM); ns, not statistically different from WT, i.e. p > 0.05, one-sample
t-test. D) Immunoblot analysis of M2AP-WT and M2AP-VL parasite lysates with anti-M2AP (left panel) or MIC5-WT and MIC5-LV parasite
lysates with anti-MIC5 (right panel).
that both M2AP-V3L and MIC5-L1V were processed
similar to the respective wild-type proteins (Figure 7D).
Aliphatic residues near the N-terminus of several
disparate microneme propeptides are required for
microneme targeting
As the propeptide deletion mapping analyses of M2AP and
MIC5 indicated that a leucine or valine near the N-terminus
is important for microneme targeting, we re-examined
the microneme propeptide sequences of AMA1, MIC3
and EtMIC5. Interestingly, all three propeptide sequences
contain leucine residues near the N-terminus (Figure 8A).
To determine if the leucine residues are important,
we made parasite cell lines containing point mutations
in AMA1, MIC3 and EtMIC5 and examined by IFA.
Results showed that M2AP trafficking was at least
partially impaired in all the mutant propeptide expressing
parasites. The AMA1-L3K and EtMIC5-L2K mutants largely
mislocalized to the endosomal system. The MIC3-L1K
mutant targeted mostly to the micronemes but a minor
subpopulation was mistargeted to the parasitophorous
vacuole (PV). Mis-trafficking of these mutants indicates
that aliphatic residues at the N-terminus are determinants
of microneme targeting for several disparate proteins
(Figure 8B,C). Immunoblot analysis revealed correct
processing of the mutant proteins, consistent with them
encountering the propeptide processing protease despite
their aberrant trafficking (Figure 8D).
Discussion
Toxoplasma gondii microneme proteins released in
response to calcium-mediated signals are not only essen-
tial for parasite entry into host cells but also for gliding
motility. Accordingly many parasite cell lines deficient in
microneme proteins such as MIC2, M2AP, AMA1 and
MIC8 are severely impaired in invasion and virulence in
mouse infections. Hence studying the synthesis, trans-
port, storage, secretion and functioning of microneme
proteins might reveal new players that could act as novel
targets for intervention. Recent studies on microneme
trafficking in T. gondii have shown that cytoplasmic
domains of transmembrane microneme proteins do not
necessarily contain sufficient signals for trafficking (22).
This view is also supported by the findings that propep-
tide domains play a crucial role in correct targeting of
microneme proteins (19–21,25). In this study, we take a
step further and show that propeptides within T. gondii
and also in the related parasite E. tenella can substitute
for one another and hence appear to function in a context
independent manner. We also define at the single residue
level that aliphatic amino acids near the N-terminus of
microneme propeptides are crucial for correct targeting to
the micronemes.
We found that the fates of M2AP and MIC5 are
different in trafficking-defective parasites, suggesting that
848 Traffic 2011; 12: 840–853





Figure 8: Leucine near the N-terminus of microneme propeptides is important for correct trafficking. A) Propeptide sequences
of M2AP, AMA1, MIC5, MIC3 and EtMIC5. B) Schematic representation of AMA1proM2AP, MIC3proM2AP and EtMIC5proM2AP in
which the N-terminal leucine residues are replaced with lysine and location of mature M2AP in intracellular parasites examined by IFA
using anti-M2AP and anti-MIC10 antibodies. MIC10 was used as the control for microneme staining. Arrows denote the site where the
mature M2AP is retained or found in the PV in trafficking-defective parasites. Scale bar: 2 μm. C) Quantification of M2AP and MIC10
colocalization. Bars represent standard error of the mean (SEM); *p < .05, one sample t test. D) Parasites stably transfected with
wild-type replacement or mutant constructs were analyzed by immunoblotting with anti-M2AP.
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Figure 9: A working model for propeptide-based targeting of M2AP and MIC5 in Toxoplasma. A) Wild-type proM2AP and proMIC5
pass through the TGN, early endosomes (EE) and late endosomes (LE). proMICs interact with hypothetical sorting receptors in the TGN,
EE and LE that guide them into a budding immature microneme where propeptide cleavage is performed by maturase(s). The sorting
receptor is then recycled back to the LE to pick up more cargo. B) Mutant proM2AP is guided through the early secretory organelles by
its binding partner MIC2 (not shown) but is arrested in the LE because of a failure to interact with the sorting receptor. Mutant proM2AP
is still processed to some extent by maturases in the LE. However, mutant proMIC5 does not have a binding partner to guide it to
LE and hence is not processed by maturases in the LE or immature microneme. Instead it is diverted to punctate structures that are
distinct from the endosomal system.
propeptides contribute to trafficking at distinct places
within the secretory pathway. Several studies have
shown that T. gondii regulated secretory pathways to the
rhoptries and micronemes involve the parasite endosomal
system including early and late endosomes (14,19,26,27).
As depicted in a working model of propeptide-based
trafficking (Figure 9), the M2AP propeptide appears to
function relatively late in the trafficking pathway as M2AP
propeptide mutants successfully navigate the ER, Golgi,
trans-Golgi network (TGN) and early endosomes but are
arrested in the late endosomes (19) prior to reaching the
micronemes (14). In contrast, trafficking signals within the
MIC5 propeptide appear to be used earlier in the secretory
system as trafficking-defective mutants are arrested or
diverted prior to reaching the late endosomes based
on immunolocalization within distinct punctate structures
and the absence of endosomal proteolytic processing.
Unlike MIC5, M2AP has a transmembrane binding partner,
MIC2, which provides sufficient targeting information
to navigate the early secretory organelles including the
ER and Golgi (15). Thereafter, M2AP appears to guide
the complex through the early endosomes to the late
endosomes where the M2AP propeptide is required for
entry into the micronemes (19). Since MIC5 does not
have a known binding partner, it likely uses its propeptide
earlier in the system, thus explaining the diversion of
such mutants to an alternative site(s). MIC3 is a distinct
case as its trafficking to the micronemes is independent
of its transmembrane partner MIC8 (12) and MIC3
propeptide mutants are diverted to the parasitophorous
vacuole, presumably via the dense granules [(21) and
Figure 8B]. These findings, together with the extensive
interchangeability of microneme propeptides, suggests
that propeptides confer a shared trafficking function albeit
at several distinct sites within the secretory system, with
the site of mutant diversion or retention reflecting the
earliest propeptide-dependent step in the pathway.
Two principal models have been proposed to explain how
propeptides facilitate targeting to the regulated secretory
pathway of eukaryotic cells. The first model, ‘sorting
by retention’ argues that propeptide cleavage triggers
a conformational shift in the mature protein, thus inducing
aggregation under the mildly acidic conditions of the
immature secretory granule (28). Aggregation promotes
retention of secretory proteins in the maturing granule
whereas proteins not intended for regulated secretion
are diverted elsewhere. Much of the data in support of
this model comes from the insulin field where it has
been shown that processing of pro-insulin dramatically
alters its structure and that mature insulin is retained
better in maturing granules than the pro-insulin precursor.
The second model, ‘sorting for entry’ involves the use
of sorting receptors that guide the selective cargo to
the regulated secretory pathway. This model is based
in part on the discovery of several putative metazoan
sorting receptors in the regulated pathway including
carboxypeptidase E (29) and granins (30,31). Also, a recent
study showed that sorting of prohormone convertase
(PC)1/3 to dense core secretory granules is mediated by
a hydrophobic patch within an α-helix near the C-terminus
of the protein that helps the protein to associate with
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the membrane (32). Interestingly, a leucine residue (L745)
within the hydrophobic patch is critical for this interaction
and mutation of this residue abolishes sorting of PC1/3 to
dense core secretory vesicles.
Previous work showing that propeptide cleavage is not
necessary for microneme targeting (19,21) and our cur-
rent finding that propeptide cleavage is not sufficient for
M2AP targeting to the micronemes (Figure 3E) is inconsis-
tent with a sorting by retention model. On the other hand,
the involvement of a sorting by entry/receptor mechanism
in microneme trafficking is attractive for three reasons.
First, propeptides reside in the lumen of secretory com-
partments and do not have direct access to the cytoplasm
where much of the sorting machinery exists. Sorting
receptors are designed to couple luminal cargo with
the cytoplasmic sorting machinery that executes vesic-
ular trafficking. Second, recognition by a sorting receptor
could explain the discrete nature of the propeptide sort-
ing element, which we show involves aliphatic residues
at or near the N-terminus of the microneme propeptide.
Such proximity to the N-terminus may impart solvent
and receptor accessibility of these key residues. Finally,
engagement of sorting receptors at distinct sites in the
secretory pathway could help explain the different fates
of microneme propeptide mutants (Figure 9).
Two of the best-characterized cargo receptors in higher
eukaryotes include the mannose-6-phosphate receptor
(MPR) (33) and sortilin (34,35), which are involved in the
trafficking of lysosomal enzymes from the TGN to the early
endosome. The luminal domain of sortilin interacts with
the cargo, while the cytoplasmic domain interacts with
adapter proteins of the vesicular trafficking machinery.
Crystal structure analysis of sortilin in association with a
cargo protein, neurotensin, has shown that a C-terminal
tripeptide motif, Tyr-Ile-Leu, of neurotensin is important
for the interaction and that the leucine residue fits into the
hydrophobic pocket of the receptor (36). Vacuolar sorting
receptors (VSRs) (37–39) in plants function in protein
trafficking from TGN to vacuole. Studies on VSR-based
trafficking of cargo proteins in plants have shown that
vacuolar targeting signals reside within propeptides of the
cargo and the aliphatic residues, isoleucine and leucine,
are critical for the interaction with VSRs (39,40).
The T. gondii genome does not encode an MPR but
contains a single sortilin gene, TgSortilin (TgME49_09160),
and two putative VSRs, TgVSR1 (TgME49_024710) and
TgVSR2 (TgME49_112860). Thus, T. gondii possesses
both animal-like and plant-like cargo receptors (41). A
preliminary analysis of these putative cargo receptors
revealed that TgSortilin and TgVSR2 are expressed in
T. gondii tachyzoites based on mRNA and protein analysis,
but TgVSR1 was not detected (data not shown). TgSortilin
and TgVSR2 both reside in late endosomes where
they colocalize with VP1. Repeated attempts to disrupt
TgSortilin were not successful implying that it is an
essential gene. Targeted disruption of TgVSR2 did not
affect microneme protein trafficking indicating a distinct or
redundant role for this putative cargo receptor. Additional
non-canonical sorting receptors might also exist. Further
studies will be necessary to determine the role of
TgSortilin or other yet-to-be-identified cargo receptors in
microneme propeptide sorting.
As no studies have been performed in other apicomplexan
parasites regarding the role of propeptides in microneme
protein trafficking, it remains unclear whether these
elements play a conserved role in parasites related to
T. gondii. Our finding that the EtMIC5 propeptide can
function in microneme protein transport in T. gondii
suggests that functional conservation exists at least within
the coccidian branch of the Apicomplexa. In addition to
functioning in microneme protein trafficking, propeptides
are emerging as important determinants of trafficking to
apicomplexan rhoptries (42,43) and export of Plasmodium
proteins into the cytosol of infected erythrocytes (43–46).
Although it remains to be determined whether conserved
mechanisms are involved, our findings suggest that the
key residues necessary for propeptide-based trafficking
can be highly discrete and therefore non-recognizable as
conserved motifs. Accordingly, determining the molecular
basis of propeptide trafficking to the rhoptries or




Toxoplasma gondii tachyzoites were maintained by passage through
human foreskin fibroblasts (HFF) in a humidified incubator at 37◦C with
5% CO2. The normal growth medium consisted of DMEM supplemented
with 10% FBS, 10 mM HEPES, 2 mM L-glutamine and 50 μg/mL penicillin
streptomycin. Purification of parasites by filtration was performed as
described previously (47).
Plasmid constructs
Primers used in generating plasmid constructs described in this section
are listed in Tables S1–S7. To obtain AMA1-M2AP, MIC3-M2AP plasmid
constructs, the signal sequence and propeptide region of AMA1 and MIC3
were amplified from cDNA library of RH strain parasites by polymerase
chain reaction (PCR) and fused with M2AP mature protein sequence by
overlap extension PCR. The final PCR products were digested with NsiI,
PacI and directionally cloned downstream of M2AP promoter in M2AP-CV
described previously (16). To make EtMIC5-M2AP and M2AP-SCR, M2AP
signal peptide fused with either EtMIC5 propeptide or scrambled M2AP
propeptide sequences were obtained as dsDNA molecules Integrated
DNA Technologies (IDT), amplified by PCR and fused with M2AP mature
open reading frame (ORF) by overlap extension PCR. The resulting PCR
products were then digested with NsiI, PacI and cloned into M2AP-CV.
All M2AP and MIC5 propeptide deletion, mutation and replacement con-
structs were made using Quik-Change II XL site-directed mutagenesis kit
(Stratagene) according to manufacturer’s instructions. Briefly, the parent
plasmids, M2AP-CV or MIC5-CV (24) were denatured and two complemen-
tary primers (forward and reverse) containing the desired mutation were
allowed to anneal. The primer extension was performed using PfuUltra
DNA polymerase and the methylated or hemimethylated parent plasmid
DNA was digested with DpnI. The newly synthesized mutated plasmid
DNA molecule was transformed into competent cells for nick repair. Plas-
mid constructs AMA1-L3K, MIC3-L1K and EtMIC5-L2K were also made
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by site-directed mutagenesis technique as described above using parent
plasmids AMA1-M2AP, MIC3-M2AP and EtMIC5-M2AP. All constructs
were verified by restriction digestion and sequencing.
Stable transformation
Plasmid constructs were electroporated into T. gondii tachyzoites
according to established protocols (48) with a combination of wild-type or
mutated propeptide construct (50 μg), and plasmid containing selectable
marker TUB-DHFR (10 μg) and added onto HFF monolayer. Parasite
populations stably expressing transfected construct were selected by
culturing in the presence of 1 μM pyrimethamine (49).
Immunoblotting
Parasite lysates were heated at 100◦C for 5 min in SDS–PAGE sam-
ple buffer with 2% 2-mercaptoethanol and resolved on 10% or 12.5%
gels. Proteins from the gel were transferred to PVDF membranes using a
semidry transfer apparatus (Bio-Rad) at 16 V for 30 min. After blocking with
10% (w/v) skim milk powder in PBS, membranes were treated with pri-
mary antibody rabbit-rM2AP (16) or rabbit-rMIC5 (50) for 1 h. Membranes
were then washed and incubated with secondary antibodies, goat-anti rab-
bit IgG conjugated to horseradish peroxidase (Jackson Immuno Research
Laboratories). After washing, membranes were treated with SuperSignal
West Pico chemiluminescent substrate (Pierce Chemical) and exposed to
X-ray film.
Immunofluorescence microscopy
Immunofluorescence staining of intracellular parasites was performed
according to previously described procedures (47). Briefly, freshly lysed
parasites were added onto confluent monolayer of HFF cells in 8-well
chamber slides. About 16 h post-infection, slides were washed three
times with PBS and fixed with 4% formaldehyde and 0.025% glutaralde-
hyde for 20 min. Fixed slides were permeabilized with 0.1% Triton-X-100
for 10 min and blocked with 10% FBS. After 30 min blocking, primary anti-
bodies diluted in 1% FBS/1% normal goat serum (NGS) were added onto
the slides. The primary antibodies used were rat anti-MIC10, rabbit anti-
M2AP, rabbit anti-MIC5, rat anti-M2AP and rabbit anti-VP1. After 1 h, slides
were washed three times with 1% FBS/1% NGS/PBS and secondary Alexa
fluorophore-conjugated antibodies were added. Secondary antibodies used
include Alexa Fluor-594- or Alexa Fluor-488-conjugated goat anti-rat or goat
anti-rabbit (Molecular Probes). After 1 h, slides were washed three times
and mounted using Mowiol (Sigma-Aldrich). Slides were viewed using an
Axio observer Z1 (Zeiss) inverted wide field fluorescent microscope, and
digital images were captured as Z-stack series using an AxioCam MRm
(Zeiss) charge-coupled device camera. The images were then deconvolved
with a regularized inverse filter algorithm and a region around the vac-
uole (four parasites per vacuole) in the deconvolved image was selected
and Pearson’s colocalization coefficient was determined using AXIOVISION
software (Zeiss).
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